Serum Fibroblast Growth Factor 21 as a Novel Biomarker in Prediction of Coronary Artery Disease Severity
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 18, Issue 9
Abstract
Aims: To evaluate serum FGF-21 concentrations in coronary heart disease patients (CHD) whether or not associated with diabetes and/or hypertension. It also investigated the possible association between serum FGF21 and the coronary angiographic findings in terms of number of coronary vessels affected. Study Design: Cross-sectional observational comparative study. Place and Duration of Study: Coronary angiography unit at the Critical Care Department with Biochemistry Department, Kasr Al Aini Medical Hospitals, from January 2013 to March 2014. Methods: Seventy patients (47 Males and 23 females) were classified after coronary angiography into: Sub-group (A): Coronary Artery Disease patients without DM or hypertension; Sub-group (B): Coronary Artery Disease patients with DM and/or hypertension; Sub-group (C): Patients with normal angiography but suffering from DM and/ or hypertension. Twelve healthy individuals were also included in the present study as a control group. Body Mass Index (BMI) were matched for all groups, systolic and diastolic blood pressure (SBP&DBP) and fasting serum levels of FGF21, glucose, insulin and lipid profile were estimated. Results: A significant increase in the levels of FGF-21 was detected in CHD patients compared to control group (325.8 ± 129.2 Vs 202.2 ± 65.8, P =.002) and significant increase was also found in those with multi-vessel disease affection compared to those with one-vessel affection group (392.1 ± 140.4 Vs 250.7 ± 83.8, P =.007), There was a highly significant positive correlation between serum levels of FGF-21 and each of BMI (r= .7, P > .001), SBP (r= .63, P > .001), and DBP (r= .67, P > .001). ROC curve analysis indicated that the optimum cut off value for plasma FGF 21 level in patients with CHD versus control was 236 pg/ml which gives 68.33% sensitivity and 75% specificity. Conclusion: Circulating FGF21 level could be a biomarker for CHD and may be used for assessment of severity of CHD.
Authors and Affiliations
Mervat M. Khalaf, Salwa Fayez, Taha Azouz
Keywords
Related Articles
- EP ID EP340953
- DOI 10.9734/BJMMR/2016/29581
- Views 49
- Downloads 0
Bone Marrow Mast Cell Density Correlates with Circulating Biomarkers of Bone Disease in Multiple Myeloma
Aims: There is increased mast cell density (MCD) in multiple myeloma (MM) bone marrow (BM) that is correlated with advanced disease stage. Mast cells (MCs) produce various mediators promoting MM growth and bone metabolis...
Psychosocial Assessment of Voice Problems among Saudi Imams
Background and Objective: Imams, who lead prayers for Muslims, are considered among professional voice users. They have high vocal demand during their prayer times, Khutbah, and educating sessions for Muslims. The aim of...
Use of Nigerian Medicinal Plants Protected Liver from Injury in Plasmodium berghei Infected Mice
The effects of ethanol leaf extracts of Spilanthes uliginosa, Ocimum basilicum, Hyptis spicigera and Cymbopogon citratus on mice infected with malaria parasite was investigated. Eighty four (84) swiss mice of both sexes...
An Update on Cephalometrics among Nigerians: Ascertaining Prevalent Jaw Patterns
Aims: Cephalometric norms vary between populations as well as among ethnicities within a known population. This study presents an update on cephalometric findings among Nigerians as well as the prevalent jaw patterns amo...
Strategies of Mothers in Life Management Along with a Child with Congenital Heart Disease: Valuable Experience of Iranian Mothers
Mothers of children with congenital heart disease used a variety of ways for caring. Mothers, caring approach is dependent on several factors: Culture, mentality and attitude, available resources. Aim: This study inves...